A modest increase in viability was observed at low concentrations (< 10 μg/mL); however, this trend did not reach statistical significance.
← all excerpts
Axitinib promotes stemness and vasculogenic mimicry in triple-negative breast cancer by disrupting THBS1-CD47 axis-mediated endothelial-tumor cell communication.
1
—
—